Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

A. Gonschior · SciRah

Researcher profile · Semantic Scholar

A. Gonschior

Share profile

A. Gonschior — researcher profile on SciRah

h-index: 10
Works: 24
Citations: 701

Most-cited papers

Metabolism of the immunosuppressant tacrolimus in the small intestine: cytochrome P450, drug interactions, and interindividual variability.
A. Lampen, U. Christians, F. Guengerich, P. Watkins +6 more
1995Drug Metabolism And Disposition282 citations
Semantic Scholar
Tacrolimus (FK506) metabolite patterns in blood from liver and kidney transplant patients.
A. Gonschior, U. Christians, M. Winkler, A. Linck +2 more
1996Clinical Chemistry82 citations
Semantic Scholar
Metabolism of the macrolide immunosuppressant, tacrolimus, by the pig gut mucosa in the Ussing chamber
A. Lampen, U. Christians, A. Gonschior, A. Bader +3 more
1996British Journal of Pharmacology75 citations Open access
Semantic Scholar
Deterioration in quality of life (QoL) in patients with malignant ascites: results from a phase II/III study comparing paracentesis plus catumaxomab with paracentesis alone
P. Wimberger, H. Gilet, A. Gonschior, M. Heiss +7 more
2012Annals of Oncology66 citations Open access
Semantic Scholar
Simplified High‐Performance Liquid Chromatography‐Mass Spectrometry Assay for Measurement of Tacrolimus and Its Metabolites and Cross‐Validation with Microparticle Enzyme Immunoassay
A. Gonschior, U. Christians, M. Winkler, H. Schiebel +2 more
1995Therapeutic Drug Monitoring47 citations
Semantic Scholar
Measurement of blood concentrations of FK506 (tacrolimus) and its metabolites in seven liver graft patients after the first dose by h.p.l.c.-MS and microparticle enzyme immunoassay (MEIA).
A. Gonschior, U. Christians, F. Braun, M. Winkler +3 more
1994British Journal of Clinical Pharmacology43 citations Open access
Semantic Scholar
Comparison of the cost-effectiveness of new oral anticoagulants for the prevention of stroke and systemic embolism in atrial fibrillation in a UK setting.
Ying Zheng, S. Sorensen, A. Gonschior, H. Noack +3 more
2014Clinical Therapeutics41 citations Open access
Semantic Scholar
Tacrolimus (FK 506) biotransformation in primary rat hepatocytes depends on extracellular matrix geometry
A. Bader, E. Knop, K. Böker, O. Crome +6 more
1996Naunyn-Schmiedeberg's Archives of Pharmacology16 citations
Semantic Scholar
Deterioration in quality of life (QoL) in patients with malignant ascites: results from a phase II/III study comparing paracentesis plus catumaxomab with paracentesis alone.
P. Wimberger, H. Gilet, A. Gonschior, M. Heiss +7 more
201212 citations Open access
Semantic Scholar
Evaluation of the Pro-Trac tacrolimus monoclonal whole-blood enzyme-linked immunosorbent assay for monitoring of tacrolimus levels in patients after kidney, heart, and liver transplantation.
M. Winkler, U. Christians, J. Baumann, A. Gonschior +2 more
1996Therapeutic Drug Monitoring11 citations
Semantic Scholar
Update in the pharmaceutical therapy of the irritable bowel syndrome
F. Thielecke, S. Maxion-Bergemann, F. Abel, A. Gonschior
2004International journal of clinical practice7 citations Open access
Semantic Scholar
Cost-Effectiveness of Dabigatran Etexilate for the Secondary Prevention of Recurrent Deep Vein Thrombosis and Pulmonary Embolism in the United Kingdom
S. Wolowacz, J. Brockbank, T. Sunderland, A. Gonschior
20135 citations Open access
Semantic Scholar
190 EVALUATION OF THE NEW PRO-TRACR TACROLIMUS MONOCLONAL WHOLE BLOOD ELISA FOR MONITORING OF TACROLIMUS LEVELS IN PATIENTS AFTER KIDNEY, HEART AND LIVER TRANSPLANT
M. Winkler, U. Christians, A. Gonschior, J. Baumann +2 more
19954 citations
Semantic Scholar
Quality of life in patients with malignant ascites and after treatment with catumaxomab: results from a phase II/III study comparing paracentesis plus catumaxomab with paracentesis alone
B. Schmalfeldt, K. Seck, A. Gonschior, H. Gilet +6 more
20122 citations
Semantic Scholar
Quality of Life in Patients With Malignant Ascites and Ascites Symptoms After Treatment With Catumaxomab: Results From a Multicenter Phase II/III Study Comparing Paracentesis Plus Catumaxomab With Paracentesis Alone
A. Gonschior, H. Gilet, Mm Heisss, M. Hennig +5 more
20112 citations
Semantic Scholar
Application of primary hepatocyte sandwich cultures for predictive studies of drug metabolism and precarcinogen activation
A. Bader, R. Fahrig, A. Steinkamp, N. Frühauf +5 more
19972 citations
Semantic Scholar
Comparative Efficacy and Safety Of Dabigatran Etexilate and Rivaroxaban For The Treatment Of Deep Vein Thrombosis and Pulmonary Embolism
A. Clemens, S. Abeysinghe, A. Gonschior, V. Hösel +4 more
20131 citations
Semantic Scholar
3004 POSTER DISCUSSION Quality of Life in Patients With Malignant Ascites and Ascites Symptoms After Treatment With Catumaxomab: Results From a Multicenter Phase ll/lll Study Comparing Paracentesis Plus Catumaxomab With Paracentesis Alone
A. Gonschior, H. Gilet, M. Heiss, M. Hennig +5 more
20111 citations
Semantic Scholar
PCN67 MANAGEMENT OF MALIGNANT ASCITES IN GERMANY—TREATMENT PATTERNS, RESOURCE CONSUMPTION, AND COSTS
B. Ehlken, K. Berger, R. Shlaen, A. Gonschior +1 more
20101 citations Open access
Semantic Scholar
136 TACROLIMUS (FK506) METABOLITE PATTERNS IN BLOOD FROM LIVER AND KIDNEY TRANSPLANT PATIENTS
A. Gonschior, U. Christians, M. Winkler, K. Sewing
19951 citations
Semantic Scholar
COMPARISON OF HEALTH AND ECONOMIC OUTCOMES OF NEW ORAL ANTICOAGULANTS FOR THE PREVENTION OF STROKE AND SYSTEMIC EMBOLISM IN ATRIAL FIBRILLATION
Ying Zheng, S. Sorensen, I. Menown, A. Gonschior +4 more
20160 citations Open access
Semantic Scholar
Pharmacoeconomic Analysis Of Dabigatran In Patients With Atrial Fibrillation: Comparison With Rivaroxaban Or Apixaban
J. Gay-Molina, S. Herrán, S. Sorensen, A. Gonschior
20140 citations Open access
Semantic Scholar
Quality of life in patients with malignant ascites during catumaxomab treatment: Results from the CASIMAS trial.
F. Lordick, J. Sehouli, I. Vergote, P. Rosenberg +16 more
20120 citations
Semantic Scholar
Quality-of-life assessment in patients with malignant ascites: Results of a multicenter phase II/III study comparing paracentesis plus catumaxomab with paracentesis alone.
A. Gonschior, M. Heiss, M. Moehler, Simon L. Parsons +1 more
2011Journal of Clinical Oncology0 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

U. Christians×8
Invite
U. Christians — researcher profile on SciRah
M. Winkler×6
Invite
M. Winkler — researcher profile on SciRah
P. Wimberger×6
Invite
P. Wimberger — researcher profile on SciRah
H. Gilet×6
Invite
H. Gilet — researcher profile on SciRah

×6

Invite

M. Moehler — researcher profile on SciRah

Invite

K. Sewing — researcher profile on SciRah

Invite

M. Heiss — researcher profile on SciRah

B. Schmalfeldt×5

Invite

B. Schmalfeldt — researcher profile on SciRah

Invite

E. Schulze — researcher profile on SciRah

Invite

S. Parsons — researcher profile on SciRah

Invite

A. Bader — researcher profile on SciRah

Invite

J. Baumann — researcher profile on SciRah